Table 165 Percent of central venous catheter placement with associated bloodstream infections or mechanical adverse events, United States, 2005a |
Population group |
Percent |
SE |
Total |
|
4.11 |
0.36 |
Age |
Under 65 |
4.37 |
0.81 |
65-74 |
3.87 |
0.62 |
75-84 |
3.84 |
0.61 |
85 and over |
5.04 |
1.16 |
Gender |
Female |
4.48 |
0.52 |
Male |
3.67 |
0.51 |
Race |
White |
3.84 |
0.39 |
Black |
5.79 |
1.17 |
Other |
3.98 |
1.47 |
Diabetes |
Yes |
4.39 |
0.60 |
No |
3.92 |
0.46 |
Obesity |
Yes |
3.18 |
0.76 |
No |
4.31 |
0.41 |
Cerebrovascular disease |
Yes |
3.49 |
0.69 |
No |
4.31 |
0.43 |
CHF/pulmonary edema |
Yes |
4.90 |
0.66 |
No |
3.67 |
0.43 |
COPD |
Yes |
3.93 |
0.63 |
No |
4.19 |
0.45 |
Smoking |
Yes |
4.48 |
0.98 |
No |
4.08 |
0.40 |
Corticosteroids |
Yes |
3.14 |
1.03 |
No |
4.21 |
0.39 |
Coronary artery disease |
Yes |
4.08 |
0.52 |
No |
4.13 |
0.51 |
Renal disease |
Yes |
4.93 |
0.62 |
No |
3.54 |
0.44 |
a Data include Medicare beneficiaries discharged from January to December.
Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; SE: standard error.
Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System.